Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 18Lymphoid 16Myeloid 3Classical hematology 2Plasma cell 1Genitourinary 1

Conditions

Carcinoma, Renal Cell 3Kidney Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 6fludarabine phosphate 4Flow Cytometry 4Antilymphocyte Serum 4Tacrolimus 3Psychiatric Rehabilitation 3Peripheral Blood Stem Cell Transplantation 3Mycophenolic Acid 3Filgrastim 3Busulfan 3Azacitidine 3Alemtuzumab 3Vincristine 2Radiotherapy 2Polymerase Chain Reaction 2Methylprednisolone 2Methotrexate 2Immunologic Techniques 2Gene Expression Profiling 2Cyclosporine 2Counseling 2Bupropion 2Blood Specimen Collection 2thymoglobulin 1tanespimycin 1sargramostim 1ruxolitinib 1rucaparib 1pembrolizumab 1motexafin gadolinium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Pentostatin × Genitourinary × Clear all
NCT00698685 2017-03-31

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

University of Arizona

Phase 2 Terminated
14 enrolled 7 charts
GenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Carcinoma, Renal Cell, Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡